BRIEF published on 09/23/2024 at 18:17, 1 month 29 days ago Funding Circle Plc: POS-Transaction in Own Shares Share Buy-back London Stock Exchange Ordinary Shares Stock Purchase Funding Circle
PRESS RELEASE published on 09/23/2024 at 18:12, 1 month 29 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces purchase of 150,000 ordinary shares for cancellation, with details of prices and transactions. Company's share capital to consist of 336,308,690 shares post-cancellation London Stock Exchange Ordinary Shares Cancellation Funding Circle Plc Buy-back
BRIEF published on 09/23/2024 at 09:08, 2 months ago Funding Circle Plc: Notification of Major Holdings Change Voting Rights Major Holdings Financial Disclosure Funding Circle Zedra Trust Company
PRESS RELEASE published on 09/23/2024 at 09:03, 2 months ago Funding Circle Plc: HOL-Holding(s) in Company* Funding Circle Plc (FCH) reports Zedra Trust Company's voting rights decrease to 2.90% on 17/9/2024 from 3.90% on 13/9/2024 Voting Rights Notification Funding Circle Plc FCH Zedra Trust Company
BRIEF published on 09/20/2024 at 19:30, 2 months 2 days ago Funding Circle Plc: Major Shareholding Changes Voting Rights Shareholding Funding Circle Index Ventures UK Regulatory
PRESS RELEASE published on 09/20/2024 at 19:25, 2 months 2 days ago Funding Circle Plc: HOL-Holding(s) in Company* Index Venture Associates V Limited has notified an acquisition of voting rights in Funding Circle Holdings PLC on 03-Sep-2024 Acquisition Major Holdings Notification Funding Circle Plc HOL-Holding
BRIEF published on 09/20/2024 at 19:24, 2 months 2 days ago Funding Circle Plc: Notice of Major Shareholding Change Voting Rights Shareholding Change Funding Circle Regulatory Update Index Ventures
PRESS RELEASE published on 09/20/2024 at 19:19, 2 months 2 days ago Funding Circle Plc: HOL-Holding(s) in Company* Index Venture Growth Associates II Limited discloses an acquisition of voting rights in Funding Circle Holdings Plc. UK Issuer, ISIN: GB00BG0TPX62 Acquisition Voting Rights Funding Circle Holdings PLC UK Issuer Index Venture Growth Associates II Limited
BRIEF published on 09/20/2024 at 18:12, 2 months 2 days ago Funding Circle Plc: POS-Transaction in Own Shares Share Buy-back London Stock Exchange Market Abuse Regulation Funding Circle Stock Cancellation
PRESS RELEASE published on 09/20/2024 at 18:07, 2 months 2 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces transaction in own shares - 189,462 shares purchased for cancellation at prices ranging from 126.50p to 128.50p on 20-Sep-2024 London Stock Exchange Share Buyback Own Shares Funding Circle Plc Transaction
Published on 11/22/2024 at 23:55, 15 hours 16 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 15 hours 41 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 16 hours 6 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 16 hours 41 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 20 hours 56 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 21 hours 17 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 22 hours 15 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 23 hours 11 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 8 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 19 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 21 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 21 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
